市场调查报告书
商品编码
1267336
脑膜炎诊断测试全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测Global Meningitis Diagnostic Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球对脑膜炎诊断测试市场的需求将从 2022 年的 2.09 亿美元增长到 2030 年的近 3.5377 亿美元,预计在 2023-2030 年研究期间达到 6.8% 的复合年增长率。
脑膜炎是大脑和脊髓周围称为脑膜的膜的炎症。 细菌、病毒、寄生虫和真菌会导致这种感染。 脑膜炎因其传染性而成为全球关注的话题。 因此,政府正在积极努力通过建立高科技诊断设施和医院来治疗患者,以根除脑膜炎。 脑膜炎是使用实验室仪器诊断的,例如快速乳胶凝集试验、高度复杂的 PCR 和免疫测定。
由于消费者对疾病早期检测需求的认识不断提高,对及时诊断和高检测准确性的需求不断增加,预计该市场将会扩大。 此外,增加诊断设施和政府资助以减轻疾病负担正在推动市场需求。 此外,脑膜炎诊断市场的发展正在受到 PCR 和下一代测序等新的尖端技术的推动,这将使诊断变得更便宜。 在预测期内,新兴国家诊断实验室设施短缺、脑膜炎诊断专家短缺等几个问题预计将限制市场扩张。
这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外,这些工具还能够全面评估全球脑膜炎诊断测试市场的每个细分市场。 脑膜炎诊断测试行业的发展和趋势为这项研究提供了一种整体方法。
本节提供了按国家和地区划分的脑膜炎诊断测试市场细分的详细数据,以帮助确定每种产品/服务的目标受众和未来商机。
本节涵盖区域展望,重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲脑膜炎诊断检测市场当前和未来的需求。 此外,我们还关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 脑膜炎诊断测试市场的主要参与者包括 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Abbott、ELITechGroup、Seegene Inc.、Luminex Corporation、Certest Biotec、IMMY、Unigen Oy。 本节概述了竞争格局,包括各种战略发展,例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。
注意:在公司简介、财务细节、近期发展等方面,基于可用信息,私人控股公司可能不包括在内。
The global demand for Meningitis Diagnostic Testing Market is presumed to reach the market size of nearly USD 353.77 MN by 2030 from USD 209 MN in 2022 with a CAGR of 6.8% under the study period 2023 - 2030.
Meningitis is an inflammation of membranes called meninges surrounding the brain and spinal cord. Bacteria, viruses, parasites, and fungi cause this infection. Due to its propensity to spread like an epidemic, meningitis has become a topic of worry on a global scale. As a result, the government is actively working to eradicate meningitis by setting up high-tech diagnostic facilities and hospitals to provide patient care. Meningitis is diagnosed using a fast latex agglutination test or extremely sophisticated PCR, immunoassay, and other testing equipment.
The market is expected to rise due to increased consumer awareness of the need for early disease detection, rising demand for quick diagnoses, and high test accuracy. Additionally, the growing number of diagnostic facilities and government funding to lessen disease burden drive market demand. Furthermore, the meningitis diagnostic market's development is fueled by new cutting-edge technologies like PCR and next-generation sequencing that offer a less expensive diagnosis. During the projection period, several issues, including a lack of diagnostic laboratory facilities in emerging nations and a scarcity of specialists in meningitis diagnosis, are projected to restrain market expansion.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of meningitis diagnostic testing. The growth and trends of meningitis diagnostic testing industry provide a holistic approach to this study.
This section of the meningitis diagnostic testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Meningitis Diagnostic Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the meningitis diagnostic testing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Abbott, ELITechGroup, Seegene Inc., Luminex Corporation, Certest Biotec, IMMY, Uniogen Oy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.